T he heartbeat is normally controlled by the primary pacemaker of the heart, i.e., the sinoatrial (SA) node. Classically, the SA node is viewed as a relatively well defined group of specialized cells located at the junction of the superior vena cava and the right atrial appendage. The exact site of dominant pacemaker activity can shift among cells within the SA node region in response to various external factors that normally affect heart rate, such as autonomic nerve stimulation. The heart also contains secondary or latent atrial pacemakers located outside of the SA node in well defined regions of the inferior right atrium at its junction with the inferior vena cava (9) . These atrial pacemakers can assume control of the heartbeat in the event of SA node failure and may also compete with primary pacemaker activity, thereby contributing to abnormal atrial rhythms, i.e., atrial arrhythmias. Although the electrical activities of both SA node and latent atrial pacemaker cells depend primarily on ion channels and transporters that reside within the plasma membrane, recent work (6) indicates that local subsarcolemmal release of intracellular Ca 2+ , i.e., Ca 2+ sparks (2) , also contributes significantly to atrial pacemaker function. This intracellular Ca 2+ release is triggered by voltage-dependent activation of T-type Ca 2+ channels and is thought to stimulate inward Na + /Ca 2+ exchange current (I Na/Ca ) to depolarize the membrane toward the action potential threshold. This review focuses primarily on the Ca 2+ -mediated mechanisms that participate in latent atrial pacemaker activity.
Multiple mechanisms contribute to the pacemaker potential
Cardiac pacemaker cells exhibit the property of automaticity as a result of a gradual depolarization of the membrane potential during electrical diastole, i.e., diastolic depolarization or the pacemaker potential. In latent atrial pacemakers, the pacemaker potential exhibits two distinct phases; an initial steep slope (D1) followed by a secondary, more gradual depolarization (D2) (Fig. 1) . The fact that pacemaker activity can be altered by manipulating the slope of these two phases independently suggests that more than one mechanism contributes to the pacemaker potential. In fact, work from numerous laboratories indicates that multiple mechanisms contribute to both SA node and latent atrial pacemaker activities, including: 1) the hyperpolarization-activated inward current (I f ), 2) inward Ttype and L-type Ca 2+ currents, 3) time-dependent decay of K + conductance, 4) I Na/Ca , and 5) low background K + conductance. The relative contribution of each current to pacemaker function is controversial.
In general, because of their low background K + conductance, atrial pacemaker cells exhibit a relatively high input resistance (a12 G:). As a result, small changes in ionic current can exert large effects on membrane voltage. Because of a relatively positive threshold potential, the action potential upstroke of both SA node and latent atrial pacemakers results primarily from activation of L-type Ca 2+ current (I Ca,L ). Depolarization during the action potential upstroke activates a delayed-rectifier K + current (I K ) that initiates repolarization, which in turn deactivates K + channels. In conjunction with a sustained background inward current, the time-dependent decay of I K generates a net inward current that flows during the diastolic interval. In latent atrial pacemakers at voltages comparable to the maximum diastolic potential (70 mV), the relatively short time constant (a200 ms) of I K decay indicates a contribution primarily during the initial phase of the pacemaker potential (Fig. 1) . In addition to the decay of K + conductance, repolarization to more negative voltages activates I f , a hyperpolarization-activated inward current that is carried primarily by Na + (4). In latent atrial pacemaker cells, hyperpolarization to 70 mV elicits a small I f with a relatively slow time constant (a3 s) of activation. Cs + blocks I f and depresses the slope of the pacemaker potential, resulting in prolongation of the pacemaker cycle length by a3050% (18 Electrical excitation of the mammalian heart originates from specialized pacemaker cells in the right atrium. Pacemaker activity depends on multiple ion channels and transport mechanisms that reside primarily within the plasma membrane. However, recent evidence indicates that intracellular Ca 2+ release from the sarcoplasmic reticulum also contributes importantly to atrial pacemaker function.
activity. Similar findings have been reported in the SA node. Clearly, other mechanisms must be operating to initiate and maintain atrial pacemaker function. This is emphasized by the fact that certain mammalian atrial pacemakers (16) , as well as pacemaker cells in the amphibian sinus venosus (13), lack I f . Latent atrial pacemaker cells lacking I f exhibit a lower frequency of pacemaker activity than those atrial pacemakers that exhibit I f (16) .
Ca
2+ release from the sarcoplasmic reticulum
In cardiac muscle, systolic Ca 2+ release from the sarcoplasmic reticulum (SR) is a fundamental event in excitation-contraction (E-C) coupling. However, several laboratories, including our own, have reported that inhibition of SR Ca 2+ release inhibits atrial pacemaker activity (8, 10, 12, 19) . In latent atrial pacemakers, inhibition of SR Ca 2+ release by ryanodine specifically decreases the slope of the secondary, late phase of the pacemaker potential, markedly prolonging the pacemaker cycle length (+170%). Addition of Cs + to block I f in the presence of ryanodine causes a further prolongation in pacemaker cycle length primarily by decreasing the initial phase of the pacemaker potential. The inhibitory effects of ryanodine on pacemaker cycle length are significantly more pronounced in latent atrial than SA node pacemakers and more pronounced than inhibition of I f by Cs + . These results suggest that diastolic SR Ca 2+ release 1) contributes to both SA node and latent atrial pacemaker activities, 2) makes a greater contribution to latent than to SA node pacemaker function, and 3) is a more significant determinant of latent atrial pacemaker activity than is I f .
T-type Ca 2+ current
An important development in our understanding of cardiac pacemaker mechanisms was the discovery that cardiac cells exhibit two inward Ca 2+ currents: the relatively large, highvoltage-threshold I Ca,L and a smaller, low-voltage-threshold Ttype Ca 2+ current (I Ca,T ) (1). L-and T-type Ca 2+ channels can be distinguished by their steady-state voltage characteristics as well as their pharmacological properties. The molecular basis of the T-type Ca 2+ channel has now been elucidated, and the channel has been cloned (3). Importantly, I Ca,T is several times larger in pacemaker than nonpacemaker cardiac cells. I Ca,T density is about fivefold higher in latent atrial pacemaker cells than in nonpacemaker atrial myocytes (20) . Compared with I Ca,L , I Ca,T is little affected by the L-type Ca 2+ channel blocking agents verapamil or nifedipine, but it is inhibited by low micromolar concentrations of Ni 2+ . In latent atrial pacemakers, 40 PM Ni 2+ inhibits I Ca,T , decreases the slope of the pacemaker potential, and prolongs pacemaker cell length. It is important to note that Ni 2+ primarily inhibits pacemaker activity by depressing the late phase of the pacemaker potential, the same phase inhibited by ryanodine. Experiments in both SA node and latent atrial pacemakers have led to the conclusion that an I Ca,T window current contributes to pacemaker activity, primarily during the secondary, late phase of the pacemaker potential (5, 20) . The contribution of I Ca,T is thought to result from the depolarizing effects of inward Ca 2+ current. However, in cardiac Purkinje cells (17) and ventricular myocytes (14) , I Ca,T is capable of triggering SR Ca 2+ release, although less effectively than I Ca,L . Both of these studies concluded that I Ca,T plays a minor role in normal E-C coupling. However, the importance of these findings may be their relevance to cardiac pacemaker function. Thus in atrial pacemaker cells both the Ni
2+
-sensitive I Ca,T and ryanodine-sensitive SR Ca 2+ release contribute to the same secondary, late phase of the pacemaker potential. Moreover, as mentioned earlier, pacemaker cells exhibit a higher density of T-type Ca 2+ channels than nonpacemaker cardiomyocytes. Together these findings suggest that, in atrial pacemaker cells, voltage-dependent activation of I Ca,T may trigger diastolic release of SR Ca
. Evidence for this idea will be presented below. cells isolated from toad sinus venosus diastolic intracellular Ca 2+ concentration shows a close association with pacemaker firing rate, leading to the conclusion that Na + /Ca 2+ exchange contributes to pacemaker activity in that species (8) . Our laboratory has used voltage clamp methods to record diastolic currents from spontaneously active latent atrial pacemaker cells (19) . Inhibition of SR Ca 2+ release by ryanodine elicited a concomitant inhibition of the inward current, the diastolic slope of the pacemaker potential, and pacemaker rate (Fig. 2, A and B) . Clamping the membrane voltage at 50 mV during the late phase of the pacemaker potential elicited a ryanodine-sensitive slow inward current (Fig. 2, C and D) . Moreover, E-adrenergic receptor stimulation with isoproterenol increased the inward current amplitude, diastolic slope, and pacemaker rate (Fig. 2,  EG) . Ryanodine inhibited each of these effects of isoproterenol. These findings are consistent with the idea that SR Ca 
Na
release during the late diastolic interval stimulates inward I Na/Ca , thereby depolarizing the pacemaker potential toward threshold. Moreover, stimulation of SR Ca 2+ release contributes significantly to the positive chronotropic effects of E-adrenergic receptor stimulation. Similar conclusions have been reported in guinea pig atria (see Ref. 15 for references) and toad sinus venosus (8).
Low-voltage-activated diastolic Ca 2+ sparks
As mentioned earlier, several laboratories, including our own, have reported that diastolic SR Ca 2+ release plays a role in atrial pacemaker function. Recent work from our laboratory has used confocal microscopy and Ca
2+
-sensitive fluorescent indicators to directly measure SR Ca 2+ release during the pacemaker potential (6) . In contrast to ventricular muscle, atrial cells generally lack a transverse tubule (T-tubule) system. As a result, E-C coupling is initiated by Ca 2+ -induced Ca 2+ release from SR that are in close proximity to the subsarcolemmal surface membrane (7). We therefore used high resolution confocal imaging of the subsarcolemmal space to measure local changes in subsarcolemmal intracellular Ca 2+ concentration ([Ca   2+ ] ss ). Simultaneous measurements of pacemaker action potentials (Fig. 3A) and [Ca 2+ ] ss (Fig. 3B) ] ss from restricted regions (a1 Pm) close to an active release site (Fig. 3C) revealed that the increase in [Ca 2+ ] ss was caused by the summation of individual local Ca 2+ release events, i.e., Ca 2+ sparks. The surface plot (Fig. 3D) The role of SR Ca 2+ release and I Na/Ca in latent atrial pacemaker activity (19) . Compared with control (A), exposure to 1 PM ryanodine (B) decreased pacemaker rate and the slope of the pacemaker potential. In control (C), voltage clamping the late pacemaker potential at 50 mV elicited a transient inward current that decayed to a background net inward current. Ryanodine (D) abolished the inward currents and decreased the slope of the pacemaker potential. Compared with control (E), 500 nM isoproterenol (Iso; F) significantly increased inward currents and the slope of the pacemaker potential. Addition of ryanodine (Rya; G) inhibited the isoproterenol-stimulated inward currents and decreased the slope of the pacemaker potential.
individual subsarcolemmal Ca 2+ sparks. When the ramp depolarization was omitted and membrane voltage was held constant (70 mV) before the voltage step, diastolic Ca 2+ release was not observed. These findings indicate that Ca 2+ release during the ramp depolarization and therefore during the late phase of the pacemaker potential is dependent on membrane depolarization rather than due to some sort of spontaneous, , suggesting that the current was due to stimulation of I Na/Ca . A similar Ca 2+ release-dependent current that develops during the late phase of the pacemaker potential was previously identified in these cells as I Na/Ca (19) . The fact the low-voltage-activated SR Ca 2+ release occurs primarily during the late phase of the pacemaker potential also appears to be related to a time-dependent restitution of SR Ca 2+ release during diastole (Fig. 1) . Indeed, in latent atrial pacemaker cells SR Ca 2+ release becomes increasingly available over time that is compatible with the pacemaker cycle length (19) . This probably is due to dynamic time-dependent processes, such as reuptake of SR Ca 2+ and recovery of Ca 2+ release channels, that occur during the diastolic interval between beats.
Further experiments (6) indicate that nonpacemaker atrial myocytes completely lack low-voltage-activated Ca 2+ release when stimulated with a ramp/step protocol. However, in single SA node pacemaker cells isolated from the same cat hearts a small, low-voltage-activated Ca 2+ release was detected at a threshold voltage of 55 mV. This finding is consistent with the effect of ryanodine to inhibit SA node pacemaker activity. It therefore appears that low-voltage-activated Ca 2+ release is specific for pacemaker cells and is not found in regular atrial muscle cells. This is consistent with the higher density of T-type Ca 2+ channels in pacemaker cells compared with nonpacemaker atrial myocytes.
Structure-function relationship
The present findings indicate that Ca 2+ release from the SR plays an important functional role in atrial pacemaker activity. Atrial pacemaker cells do not contain T-tubules, and therefore the subsarcolemmal SR cisternae are located along the cell periphery. Latent atrial pacemaker cells exhibit morphological and ultrastructural features similar, though not identical, to pacemaker cells (P cells) located in the SA node region (11, 18) . Both types of pacemaker cells are relatively small in diameter (57 Pm) and exhibit tapered ends, sparse, randomly oriented myofibrillar material, and numerous mitochondria. The main distinguishing characteristic is the unique architecture of subsarcolemmal SR cisternae in latent atrial pacemaker cells. As shown in Fig. 4 , electron micrographs of latent atrial pacemaker cells show prominent subsarcolemmal SR cisternae that are directly apposed to one another between two adjacent cells. This structure is not seen in SA node tissue from the same hearts. Between each subsarcolemmal SR cistern and the cell membrane is diffuse, electron-dense material that corresponds to the "feet" structures or ryanodine receptors. Moreover, along the region of SR apposition, the two cell membranes invariably come together at a distance of a25 nm. This distance is similar to the subsarcolemmal space located between the surface membrane and the nearest margin of SR membrane (2022 nm), which is generally considered to be a restricted space. How this unique SR architecture is relevant to latent atrial pacemaker activity is not clear. However, as shown in the schematic diagram (Fig. 4B) , we speculate that this region may represent a modified form of a T-tubule-SR complex or triad commonly seen in ventricular muscle. Because these pacemaker cells contain relatively little myofibrillar material, it seems unlikely that this structure is relevant to E-C coupling. However, like T-tubules, Ca 2+ channels (in this case T-type) and Na + /Ca 2+ exchangers may be colocalized and more concentrated within this region. A higher density of T-type Ca 2+ channels would result in a more efficient trigger for diastolic SR Ca 2+ release, and a higher density of Na + /Ca 2+ exchangers would provide a more effective means of developing net inward current. Moreover, a restricted extracellular space at the apposed SR region may indicate as yet unknown mechanisms by which pacemaker cells communicate to facilitate SR Ca 2+ release. When latent atrial pacemakers function as dominant pacemakers, the functional properties resulting from this unique architecture may increase the margin of safety for generating coordinated pacemaker activity among groups of pacemaker cells.
Conclusions
Multiple mechanisms contribute to atrial pacemaker activity (Fig. 1) . The present work demonstrates a novel pacemaker mechanism in which voltage-dependent activation of I Ca,T triggers diastolic SR Ca 2+ release, which in turn stimulates inward I Na/Ca to depolarize the late phase of the pacemaker potential toward threshold. Depolarization during the late pacemaker potential is expected to elicit further activation of I Ca,T , resulting in a positive feedback. This mechanism suggests that I Ca,T serves a dual function during the pacemaker potential: 1) to carry a small inward Ca 2+ current and 2) to trigger release of SR Ca
2+
. The latter Ca 2+ -induced Ca 2+ release mechanism, typically associated with E-C coupling, is expected to amplify and temporally integrate the depolarizing effects of T-type Ca 2+ channel activation by stimulating a larger secondary inward I Na/Ca during the pacemaker potential. On the basis of this mechanism, interventions that alter SR Ca 2+ content and/or release are expected to regulate atrial pacemaker activity. In fact, stimulation of SR Ca 2+ uptake and release appears to underlie E-adrenergic receptor stimulation of latent atrial pacemaker activity. In this scenario, I Ca,L acts primarily to regulate T he distance between the cellular outer membrane and the nucleus seems to be tiny, only 20 Pm. Yet that minute distance encompasses a major mystery: how do the cells of higher organisms respond to the many growth signals that they receive from the environment? The answer is crucial to understanding such long-standing questions in cell biology as what causes cancer and how cellular growth is initiated or arrested. It has been well established that growth factors (mitogens) bind to specific receptors located on the cellular membrane. The mitogen-receptor complexes then trigger a cascade of events, including the activation of Ras by converting it from the GDP bound form to the GTP form. The activation of protein kinases is considered to be the next step in signal transduction, and we now recognize its critical role in the regulation of cell growth . Because latent atrial pacemakers are more dependent on low-voltage-activated SR Ca 2+ release than primary pacemakers, they may be more susceptible to Ca 2+ -mediated dysrhythmic activities. Moreover, diastolic SR Ca 2+ release may play a more important role in generating activity in pacemaker cells lacking I f . An understanding of the different mechanisms underlying atrial pacemaker activity may provide insight into the etiology and ultimate prevention of certain types of atrial arrhythmias.
